Activation of Inflammatory and Pro-Thrombotic Pathways in Acute Stress Cardiomyopathy

Stress cardiomyopathy (SCM) is a unique cardiac disorder that more often occurs in women. SCM presents in a similar fashion as acute myocardial infarction (AMI), with chest pain, ECG changes, and congestive heart failure. The primary distinguishing feature is the absence of thrombotic coronary occlu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in cardiovascular medicine 2017-08, Vol.4, p.49-49
Hauptverfasser: Fitzgibbons, Timothy P, Edwards, Yvonne J K, Shaw, Peter, Iskandar, Aline, Ahmed, Mohamed, Bote, Josiah, Shah, Tejen, Sinha, Sumita, Gerszten, Robert E, Keaney, Jr, John F, Zile, Michael R, Aurigemma, Gerard P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Stress cardiomyopathy (SCM) is a unique cardiac disorder that more often occurs in women. SCM presents in a similar fashion as acute myocardial infarction (AMI), with chest pain, ECG changes, and congestive heart failure. The primary distinguishing feature is the absence of thrombotic coronary occlusion in SCM. How this reduction in cardiac function occurs in the absence of coronary occlusion remains unknown. Therefore, we tested the hypothesis that a targeted proteomic comparison of patients with acute SCM and AMI might identify relevant mechanistic differences. Blood was drawn in normal controls (  = 6), women with AMI (  = 12), or women with acute SCM (  = 15). Two-week follow-up samples were available in AMI (  = 4) and SCM patients (  = 11). Relative concentrations of 1,310 serum proteins were measured in each of the 48 samples using the SOMAscan assay. Women with AMI had greater myocyte necrosis, as reflected by a higher peak troponin I concentration (AMI 32.03 ± 29.46 vs. SCM 2.68 ± 2.6 ng/ml,  
ISSN:2297-055X
2297-055X
DOI:10.3389/fcvm.2017.00049